Rformed independently three times at least. doi:10.1371/journal.pone.0055615.gOverexpression of SPI1005 web bKlotho Suppresses Tumor FormationTo determine whether bKlotho was involved in tumorgenesis, we further examined the effect of bKlotho on tumorgenesis in vivo using a xenograft mouse model. Hepatoma cells were transfected with vector or bKlotho, and then injected subcutaneously into nude mice to initiate tumor formation. At 4 weeks after tumor cell inoculation, large tumors were seen in the vector groups, while the tumor volume was still minimal in those mice transplanted with the bKlotho-expression cells (Fig. 5A, 5B). At the end of experiments tumors were isolated (Fig. 5C) and the mean tumor weight was significantly less in bKlotho-transfected nude mice as compared with the vector control mice (Fig. 5D). These results were consistent with the anti-proliferation function of bKlotho and indicated that bKlotho overexpression elicited a strong anti-tumor effect on HCC in vivo. We also analyzed the Akt/GSK-3b/cyclin D1 signaling in these tumors. We confirmed that bKlotho was overexpressed successfully. bKlotho-transfected tumors showed a decreased expression level of cyclin D1 and phosphorylation level of Akt and GSK-3b (Fig. 5E), which were similar to the results in vitro. To demonstrate the bKlotho effects in suppressing tumor xenograft growth was occurring through Akt/GSK-3b/cyclin D1 signaling pathway, hepatoma cells were co-transfected with bKlotho and constitutively activated Akt (myr-Akt). The Akt activity could override the suppressive effects of bKlotho (Fig. 5F). Taken together, we found that overexpression of bKlotho suppressed tumor formation by regulating Akt/GSK-3b/cyclin D1 signaling pathway.DiscussionOur observations identified bKlotho could suppress tumor growth in HCC. We found that bKlotho expression was frequently decreased in primary HCC tissues compared with their adjacentnon-tumor tissues, and was also significantly down-regulated in hepatoma cell lines. Furthermore, reintroduction of bKlotho into hepatoma cells inhibited their proliferation. The anti-proliferation effect of bKlotho might be linked with G1to S phase arrest, which was mediated by the Akt/GSK-3b/cyclin D1 signaling. bKlotho overexpression could also suppress tumorigenesis in the xenograft mouse model, while constitutively activated Akt could override the suppressive effects of bKlotho. These findings suggest bKlotho has 18325633 an anti-tumorigenic role in HCC. bKlotho is a metabolic regulator and is involved in bile acid biosynthesis[2,24]. The bKlotho-null mice exhibit increased synthesis and excretion of bile acid. It is reported that chronically higher levels of bile acids can promote liver tumor formation, suggesting an intriguing link between metabolic regulation and HCC[25,26]. Recently, bKlotho was found down-regulated in hepatoma cells and could inhibit tumor cell proliferation[4]. However, another study demonstrated that bKlotho was elevated in HCC tissues and bKlotho-silencing decreased cell proliferation[5]. These results are conflicting and thus the exact role of bKlotho in hepatocarcinogenesis has remained unclear. We and others found that bKlotho is predominantly expressed in normal liver tissue[1], while its expression was frequently decreased in primary HCC tissues and hepatoma cell lines. This Dimethylenastron implied bKlotho had a blocking effect on HCC. Moreover, reintroduction of bKlotho into hepatoma cells inhibited their proliferation. Besides the in vitro dat.Rformed independently three times at least. doi:10.1371/journal.pone.0055615.gOverexpression of bKlotho Suppresses Tumor FormationTo determine whether bKlotho was involved in tumorgenesis, we further examined the effect of bKlotho on tumorgenesis in vivo using a xenograft mouse model. Hepatoma cells were transfected with vector or bKlotho, and then injected subcutaneously into nude mice to initiate tumor formation. At 4 weeks after tumor cell inoculation, large tumors were seen in the vector groups, while the tumor volume was still minimal in those mice transplanted with the bKlotho-expression cells (Fig. 5A, 5B). At the end of experiments tumors were isolated (Fig. 5C) and the mean tumor weight was significantly less in bKlotho-transfected nude mice as compared with the vector control mice (Fig. 5D). These results were consistent with the anti-proliferation function of bKlotho and indicated that bKlotho overexpression elicited a strong anti-tumor effect on HCC in vivo. We also analyzed the Akt/GSK-3b/cyclin D1 signaling in these tumors. We confirmed that bKlotho was overexpressed successfully. bKlotho-transfected tumors showed a decreased expression level of cyclin D1 and phosphorylation level of Akt and GSK-3b (Fig. 5E), which were similar to the results in vitro. To demonstrate the bKlotho effects in suppressing tumor xenograft growth was occurring through Akt/GSK-3b/cyclin D1 signaling pathway, hepatoma cells were co-transfected with bKlotho and constitutively activated Akt (myr-Akt). The Akt activity could override the suppressive effects of bKlotho (Fig. 5F). Taken together, we found that overexpression of bKlotho suppressed tumor formation by regulating Akt/GSK-3b/cyclin D1 signaling pathway.DiscussionOur observations identified bKlotho could suppress tumor growth in HCC. We found that bKlotho expression was frequently decreased in primary HCC tissues compared with their adjacentnon-tumor tissues, and was also significantly down-regulated in hepatoma cell lines. Furthermore, reintroduction of bKlotho into hepatoma cells inhibited their proliferation. The anti-proliferation effect of bKlotho might be linked with G1to S phase arrest, which was mediated by the Akt/GSK-3b/cyclin D1 signaling. bKlotho overexpression could also suppress tumorigenesis in the xenograft mouse model, while constitutively activated Akt could override the suppressive effects of bKlotho. These findings suggest bKlotho has 18325633 an anti-tumorigenic role in HCC. bKlotho is a metabolic regulator and is involved in bile acid biosynthesis[2,24]. The bKlotho-null mice exhibit increased synthesis and excretion of bile acid. It is reported that chronically higher levels of bile acids can promote liver tumor formation, suggesting an intriguing link between metabolic regulation and HCC[25,26]. Recently, bKlotho was found down-regulated in hepatoma cells and could inhibit tumor cell proliferation[4]. However, another study demonstrated that bKlotho was elevated in HCC tissues and bKlotho-silencing decreased cell proliferation[5]. These results are conflicting and thus the exact role of bKlotho in hepatocarcinogenesis has remained unclear. We and others found that bKlotho is predominantly expressed in normal liver tissue[1], while its expression was frequently decreased in primary HCC tissues and hepatoma cell lines. This implied bKlotho had a blocking effect on HCC. Moreover, reintroduction of bKlotho into hepatoma cells inhibited their proliferation. Besides the in vitro dat.
